Robert Gerstl

Array ( [id] => 3628347 [patent_doc_number] => 05686424 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => '2-oxoethyl derivatives as immunosuppressants' [patent_app_type] => 1 [patent_app_number] => 8/431390 [patent_app_country] => US [patent_app_date] => 1995-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29524 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686424.pdf [firstpage_image] =>[orig_patent_app_number] => 431390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622274 [patent_doc_number] => 05593976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds' [patent_app_type] => 1 [patent_app_number] => 8/426130 [patent_app_country] => US [patent_app_date] => 1995-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5195 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593976.pdf [firstpage_image] =>[orig_patent_app_number] => 426130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3548126 [patent_doc_number] => 05545666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Prostaglandin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/290745 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7785 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545666.pdf [firstpage_image] =>[orig_patent_app_number] => 290745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3531022 [patent_doc_number] => 05583158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Prostaglandin E.sub.1 analogues' [patent_app_type] => 1 [patent_app_number] => 8/416871 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5801 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583158.pdf [firstpage_image] =>[orig_patent_app_number] => 416871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3525528 [patent_doc_number] => 05504097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein' [patent_app_type] => 1 [patent_app_number] => 8/423061 [patent_app_country] => US [patent_app_date] => 1995-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10600 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/504/05504097.pdf [firstpage_image] =>[orig_patent_app_number] => 423061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3614312 [patent_doc_number] => 05510360 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Azolidinediones as antihypergylcemic agents' [patent_app_type] => 1 [patent_app_number] => 8/421111 [patent_app_country] => US [patent_app_date] => 1995-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15215 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 265 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510360.pdf [firstpage_image] =>[orig_patent_app_number] => 421111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3532506 [patent_doc_number] => 05583255 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Yellow and magenta chromogenic leuco dyes for photothermographic elements' [patent_app_type] => 1 [patent_app_number] => 8/420112 [patent_app_country] => US [patent_app_date] => 1995-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11296 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583255.pdf [firstpage_image] =>[orig_patent_app_number] => 420112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516775 [patent_doc_number] => 05512689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives' [patent_app_type] => 1 [patent_app_number] => 8/417502 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3008 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512689.pdf [firstpage_image] =>[orig_patent_app_number] => 417502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3522734 [patent_doc_number] => 05489594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-06 [patent_title] => 'Platelet aggregation inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/413671 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19978 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 398 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/489/05489594.pdf [firstpage_image] =>[orig_patent_app_number] => 413671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588379 [patent_doc_number] => 05550147 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same' [patent_app_type] => 1 [patent_app_number] => 8/413939 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13315 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550147.pdf [firstpage_image] =>[orig_patent_app_number] => 413939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734734 [patent_doc_number] => 05665888 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Protected aminothiazolylacetic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 8/412190 [patent_app_country] => US [patent_app_date] => 1995-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8223 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665888.pdf [firstpage_image] =>[orig_patent_app_number] => 412190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3587576 [patent_doc_number] => 05552431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Peptide mimetic compounds useful as platelet aggregation inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/410441 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14189 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552431.pdf [firstpage_image] =>[orig_patent_app_number] => 410441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3603180 [patent_doc_number] => 05578620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Thiazolidine and oxazolidine derivatives, their preparation and their medical use' [patent_app_type] => 1 [patent_app_number] => 8/410033 [patent_app_country] => US [patent_app_date] => 1995-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48064 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 946 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578620.pdf [firstpage_image] =>[orig_patent_app_number] => 410033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3575272 [patent_doc_number] => 05523311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-04 [patent_title] => 'Process and a composition for immunizing plants against disease' [patent_app_type] => 1 [patent_app_number] => 8/405488 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28841 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/523/05523311.pdf [firstpage_image] =>[orig_patent_app_number] => 405488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3967282 [patent_doc_number] => 05886034 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Prostaglandins E and anti ulcers containing same' [patent_app_type] => 1 [patent_app_number] => 8/401675 [patent_app_country] => US [patent_app_date] => 1995-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 23175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886034.pdf [firstpage_image] =>[orig_patent_app_number] => 401675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3558825 [patent_doc_number] => 05500408 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-19 [patent_title] => 'Thiadiazole derivatives and herbicide compositions containing the same' [patent_app_type] => 1 [patent_app_number] => 8/401269 [patent_app_country] => US [patent_app_date] => 1995-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20835 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/500/05500408.pdf [firstpage_image] =>[orig_patent_app_number] => 401269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3853950 [patent_doc_number] => 05767309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Processes for preparing ›L!- or ›D!-homoalanin-4-yl-(methyl)phosphinic acid and salts thereof by racemate resolution' [patent_app_type] => 1 [patent_app_number] => 8/398216 [patent_app_country] => US [patent_app_date] => 1995-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5610 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767309.pdf [firstpage_image] =>[orig_patent_app_number] => 398216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622532 [patent_doc_number] => 05593993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Method for inhibition of HIV related viruses' [patent_app_type] => 1 [patent_app_number] => 8/395702 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 127847 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 512 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593993.pdf [firstpage_image] =>[orig_patent_app_number] => 395702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769875 [patent_doc_number] => 05733882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Retroviral protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/396356 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46656 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 746 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733882.pdf [firstpage_image] =>[orig_patent_app_number] => 396356 [rel_patent_id] =>[rel_patent_doc_number] =>)